Rosenfield RL, Ehrmann DA. The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited. Endocr Rev. 2016;37(5):467–520.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ganie MA, et al. Epidemiology, pathogenesis, genetics & management of polycystic ovary syndrome in India. Indian J Med Res. 2019;150(4):333–44.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Skiba MA, et al. Understanding variation in prevalence estimates of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2018;24(6):694–709.

Article  PubMed  Google Scholar 

Torres PJ, et al. Gut microbial diversity in women with polycystic ovary syndrome correlates with hyperandrogenism. J Clin Endocrinol Metab. 2018;103(4):1502–11.

Article  PubMed  PubMed Central  Google Scholar 

Qi X, et al. Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome. Nat Med. 2019;25(8):1225–33.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chu W, et al. Metagenomic analysis identified microbiome alterations and pathological association between intestinal microbiota and polycystic ovary syndrome. Fertil Steril. 2020;113(6):1286–98. e4.

Article  CAS  PubMed  Google Scholar 

Zhao H, et al. Modified Banxia Xiexin decoction ameliorates polycystic ovarian syndrome with insulin resistance by regulating intestinal microbiota. Front Cell Infect Microbiol. 2022;12:854796.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang YL et al. Intestinal flora is a key factor in insulin resistance and contributes to the development of polycystic ovary syndrome. Endocrinology. 2021;162(10).

Ascani A et al. The role of B cells in immune cell activation in polycystic ovary syndrome. Elife. 2023;12.

Kicinska AM et al. Immunological and metabolic causes of infertility in polycystic ovary syndrome. Biomedicines. 2023;11(6).

Zhang F, et al. Diversity of the gut microbiota in dihydrotestosterone-induced PCOS rats and the pharmacologic effects of Diane-35, probiotics, and berberine. Front Microbiol. 2019;10:175.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Camara NO, et al. Kidney disease and obesity: epidemiology, mechanisms and treatment. Nat Rev Nephrol. 2017;13(3):181–90.

Article  PubMed  Google Scholar 

Azziz R, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016;2:16057.

Article  PubMed  Google Scholar 

Dumesic DA, Abbott DH, Chazenbalk GD. An evolutionary model for the ancient origins of polycystic ovary syndrome. J Clin Med. 2023;12(19).

Vink JM, et al. Heritability of polycystic ovary syndrome in a Dutch twin-family study. J Clin Endocrinol Metab. 2006;91(6):2100–4.

Article  CAS  PubMed  Google Scholar 

Kahsar-Miller MD, et al. Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS. Fertil Steril. 2001;75(1):53–8.

Article  CAS  PubMed  Google Scholar 

Welt CK, et al. Variants in DENND1A are associated with polycystic ovary syndrome in women of European ancestry. J Clin Endocrinol Metab. 2012;97(7):E1342–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Saxena R, et al. Han Chinese polycystic ovary syndrome risk variants in women of European ancestry: relationship to FSH levels and glucose tolerance. Hum Reprod. 2015;30(6):1454–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jones MR, et al. Systems genetics reveals the functional context of PCOS loci and identifies genetic and molecular mechanisms of disease heterogeneity. PLoS Genet. 2015;11(8):e1005455.

Article  PubMed  PubMed Central  Google Scholar 

Shi Y, et al. Genome-wide association study identifies eight new risk loci for polycystic ovary syndrome. Nat Genet. 2012;44(9):1020–5.

Article  CAS  PubMed  Google Scholar 

Hayes MG, et al. Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations. Nat Commun. 2015;6:7502.

Article  CAS  PubMed  Google Scholar 

Stavridis K et al. Bisphenol-A and female fertility: an update of existing epidemiological studies. J Clin Med. 2022;11(23).

Jurewicz J, et al. Serum bisphenol a analogues in women diagnosed with the polycystic ovary syndrome - is there an association? Environ Pollut. 2021;272:115962.

Article  CAS  PubMed  Google Scholar 

Gu J, et al. Urinary concentration of personal care products and polycystic ovary syndrome: a case-control study. Environ Res. 2019;168:48–53.

Article  CAS  PubMed  Google Scholar 

Prabhu NB, et al. Distinct metabolic signatures in blood plasma of bisphenol A-exposed women with polycystic ovarian syndrome. Environ Sci Pollut Res Int. 2023;30(23):64025–35.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bellver J, et al. Polycystic ovary syndrome throughout a woman’s life. J Assist Reprod Genet. 2018;35(1):25–39.

Article  PubMed  Google Scholar 

Chen ZJ, et al. Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nat Genet. 2011;43(1):55–9.

Article  PubMed  Google Scholar 

Lund LH, et al. Association of spironolactone use with all-cause mortality in heart failure: a propensity scored cohort study. Circ Heart Fail. 2013;6(2):174–83.

Article  CAS  PubMed  Google Scholar 

Lima PDA, et al. Polycystic ovary syndrome: possible involvement of androgen-induced, chemerin-mediated ovarian recruitment of monocytes/macrophages. Biol Reprod. 2018;99(4):838–52.

Article  PubMed  PubMed Central  Google Scholar 

Cassar S, et al. Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies. Hum Reprod. 2016;31(11):2619–31.

Article  CAS  PubMed  Google Scholar 

Chen Z et al. Impact of preservation method and 16S rRNA hypervariable region on gut microbiota profiling. mSystems. 2019;4(1).

Zmora N, et al. Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features. Cell. 2018;174(6):1388–405. e21.

Article  CAS  PubMed  Google Scholar 

Zmora N, Suez J, Elinav E. You are what you eat: diet, health and the gut microbiota. Nat Rev Gastroenterol Hepatol. 2019;16(1):35–56.

Article  CAS  PubMed  Google Scholar 

Fan Y, Pedersen O. Gut microbiota in human metabolic health and disease. Nat Rev Microbiol. 2021;19(1):55–71.

Article  CAS  PubMed  Google Scholar 

Gentile CL, Weir TL. The gut microbiota at the intersection of diet and human health. Science. 2018;362(6416):776–80.

Article  CAS  PubMed  Google Scholar 

Gilbert JA, et al. Current understanding of the human microbiome. Nat Med. 2018;24(4):392–400.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Falony G, et al. The human microbiome in health and disease: hype or hope. Acta Clin Belg. 2019;74(2):53–64.

Article  PubMed  Google Scholar 

Tremellen K, Pearce K. Dysbiosis of gut microbiota (DOGMA)--a novel theory for the development of polycystic ovarian syndrome. Med Hypotheses. 2012;79(1):104–12.

Article  PubMed  Google Scholar 

Lindheim L, et al. Alterations in gut microbiome composition and barrier function are associated with reproductive and metabolic defects in women with polycystic ovary syndrome (PCOS): a pilot study. PLoS ONE. 2017;12(1):e0168390.

Article  PubMed  PubMed Central  Google Scholar 

Furusawa Y, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 2013;504(7480):446–50.

Article  CAS  PubMed  Google Scholar 

Qin L, et al. Differential expression profile of immunological cytokines in local ovary in patients with polycystic ovarian syndrome: analysis by flow cytometry. Eur J Obstet Gynecol Reprod Biol. 2016;197:136–41.

Article  CAS  PubMed  Google Scholar 

Atarashi K, et al. Treg induction by a rationally selected mixture of clostridia strains from the human microbiota. Nature. 2013;500(7461):232–6.

Article  CAS  PubMed  Google Scholar 

Yang Y, et al. The abnormal level of HSP70 is related to Treg/Th17 imbalance in PCOS patients. J Ovarian Res. 2021;14(1):155.